[ASAP] Investigation of Protein Therapeutics in Frozen Conditions Using DNP MAS NMR: A Study on Pembrolizumab 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00929 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon